Christina John
Family · Houston, TXNPI 1437789906
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.9% of the total across 103 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 17.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $2,041 and has fallen 85.5% since, to $296 in 2025. Among family clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 103 payments — averaging $42.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$760
- GSK$516
- Optinose US, Inc.$474
- Alk-abello, Inc$442
- Incyte Corporation$387
- Sanofi$339
- plus $1K from 16 others
What the payments were for
- Food & beverage$4,26498%
- Education$902%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 12 | $760 |
| GSK | 14 | $516 |
| Optinose US, Inc. | 12 | $474 |
| Alk-abello, Inc | 16 | $442 |
| Incyte Corporation | 6 | $387 |
| Sanofi | 8 | $339 |
| Grifols USA, LLC | 1 | $220 |
| Regeneron Healthcare Solutions, Inc. | 7 | $220 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $195 |
| ADMA Biomanufacturing LLC | 1 | $171 |
| Teva Pharmaceuticals USA, Inc. | 1 | $125 |
| Johnson & Johnson | 1 | $83 |
| Amgen | 4 | $83 |
| Pfizer | 1 | $80 |
| Novartis | 4 | $73 |
| Genentech USA, Inc. | 4 | $38 |
| Aimmune Therapeutics, Inc. | 2 | $33 |
| Hikma Pharmaceuticals USA | 1 | $25 |
| LEO Pharma Inc. | 1 | $24 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $24 |
| AbbVie | 1 | $22 |
| Covis Pharma GmbH | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Xhance$372
- OPZELURA$262
- TRELEGY ELLIPTA$234
- Xembify$220
- TEZSPIRE$125
- NUCALA$125
- AirDuo RespiClick$125
- ArmonAir Digihaler$125
- ProAir Digihaler$125
- BREZTRI$120
- CINRYZE$119
How this compares
$4,354 in reported general payments places this provider in the 90th percentile of 15,456 family providers in Texas.
Other family in Houston
- Robin BeachHouston$428K
- Sarah AguilarHouston$199K
- Margaret WhiteHouston$85K
- Cheryl HaseebHouston$42K
- Kendrick ClackHouston$28K
- David WeirDallas$959K
- April LopezMcAllen$417K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
- Jill CampbellShenandoah$182K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.